Finance

Lists
JUBLPHARMA:NSE
Jubilant Pharmova Ltd
935,00 INR
-0,34%
(-3,20) 1D
16 ოქტ, 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for JUBLPHARMA...
Open
938,20 INR
High
954,90 INR
Low
928,60 INR
Mkt. cap
148,11 მლრ.
Avg. vol.
329,62 ათ.
Volume
134,97 ათ.
Dividend
0,53%
Quarterly dividend
1,25 INR
Ex-dividend date
24 ივლ. 2026
P/E ratio
42,17
52-wk high
1 184,80 INR
52-wk low
786,05 INR
EPS
22,17 INR
No. of employees
6 ათ.
Open
938,20 INR
High
954,90 INR
Low
928,60 INR
Mkt. cap
148,11 მლრ.
Avg. vol.
329,62 ათ.
Volume
134,97 ათ.
Dividend
0,53%
Quarterly dividend
1,25 INR
Ex-dividend date
24 ივლ. 2026
P/E ratio
42,17
52-wk high
1 184,80 INR
52-wk low
786,05 INR
EPS
22,17 INR
No. of employees
6 ათ.
News stories
From web sources and news partners
Opening Bell Daily
Opening Bell Daily
·
41 წუთის წინ
Stock market after midterms: S&P 500 up all 19 times
Simply Wall Street
Simply Wall Street
·
1 საათის წინ
Aura Minerals (NasdaqGS:AUGO) Shares Just Moved, So What Is Going On?
About Jubilant Pharmova Ltd
CEO-
Employees5,66 ათ.
Founded1978
Headquartersნოიდა, უტარ-პრადეში, ინდოეთი
SectorPharmaceutical industry
Last report
10 აგვ. 2026
Fiscal period
Q1 2027
3,56 INR / 5,80 INR
-38,62%miss
Revenue / Est. (INR)
22,29 მლრდ. / 22,62 მლრდ.
-1,44%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
19,66 მლრდ.
21,22 მლრდ.
22,90 მლრდ.
22,29 მლრდ.
Cost of goods sold
5,96 მლრდ.
7,16 მლრდ.
9,53 მლრდ.
7,49 მლრდ.
Cost of revenue
5,96 მლრდ.
7,16 მლრდ.
9,53 მლრდ.
7,49 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,36 მლრდ.
7,06 მლრდ.
8,34 მლრდ.
7,54 მლრდ.
Operating expense
11,33 მლრდ.
12,37 მლრდ.
11,14 მლრდ.
13,60 მლრდ.
Total operating expenses
17,30 მლრდ.
19,54 მლრდ.
20,68 მლრდ.
21,09 მლრდ.
Operating income
2,37 მლრდ.
1,69 მლრდ.
2,22 მლრდ.
1,21 მლრდ.
Other non operating income
98,00 მლნ.
205,00 მლნ.
-369,00 მლნ.
199,00 მლნ.
EBT including unusual items
1,90 მლრდ.
934,00 მლნ.
1,76 მლრდ.
864,00 მლნ.
EBT excluding unusual items
1,96 მლრდ.
1,33 მლრდ.
1,87 მლრდ.
864,00 მლნ.
Income tax expense
704,00 მლნ.
376,00 მლნ.
567,00 მლნ.
300,00 მლნ.
Effective tax rate
36,99%
40,26%
32,22%
34,72%
Other operating expenses
3,92 მლრდ.
4,10 მლრდ.
1,63 მლრდ.
4,79 მლრდ.
Net income
1,20 მლრდ.
559,00 მლნ.
1,19 მლრდ.
565,00 მლნ.
Net profit margin
6,12%
2,63%
5,21%
2,53%
Earnings per share
7,85
5,01
8,10
3,56
Interest and investment income
-
-
252,00 მლნ.
-
Interest expense
-502,00 მლნ.
-561,00 მლნ.
-461,00 მლნ.
-542,00 მლნ.
Net interest expenses
-502,00 მლნ.
-561,00 მლნ.
-209,00 მლნ.
-542,00 მლნ.
Depreciation and amortization charges
1,05 მლრდ.
1,21 მლრდ.
1,17 მლრდ.
1,27 მლრდ.
EBITDA
3,38 მლრდ.
2,30 მლრდ.
2,98 მლრდ.
1,96 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები